米国の微生物学と細菌培養培地の市場規模、シェア、動向分析レポート：製品別、用途別、セグメント予測、2025年～2030年

米国の微生物学と細菌培養培地市場の成長と動向

Grand View Research, Incの最新レポートによると、米国の微生物学と細菌培養培地市場規模は2030年までに29億5,000万米ドルに達すると予測され、2025年から2030年までのCAGRは7.47％で成長すると予測されています。

この成長は、迅速診断の需要増加、感染症の流行増加、医薬品および食品検査アプリケーションの拡大、臨床および産業部門にわたる微生物培養技術の継続的な進歩に起因しています。

抗菌薬耐性（AMR）の脅威の高まりにより、薬剤耐性病原体を正確に同定するための微生物培養培地への依存度が著しく高まっています。病原体が従来の抗生物質に対する耐性を進化させるにつれ、効果的な治療戦略を導くためには正確な微生物検出が不可欠となっています。このような意識の高まりは、AMR対策に向けた研究開発の強化に拍車をかけ、高度な細菌培養培地への需要を煽っています。その結果、微生物培養は医薬品開発、感染制御、臨床診断において不可欠なツールであり続け、地域全体の市場成長を後押ししています。

さらに、自動化システムや洗練された同定方法など、培養技術における継続的な技術進歩が微生物学研究室に革命をもたらしています。これらの技術革新はワークフローを合理化し、手作業によるミスを減らし、微生物検出の精度と速度を大幅に向上させています。サンプル処理とデータ解析の効率向上により、検査室は迅速で信頼性の高い結果に対する高まる要求に応えることができます。さらに、このような改善は、製薬、臨床、研究の現場における規制遵守と品質保証をサポートします。このような進歩が培地採用の増加を促し、微生物学市場の持続的成長と競合を刺激しています。

しかし、先進的な機器や培地に関連するコストが高いため、特に小規模な検査室や新興市場での採用には限界があります。さらに、一部の自動化システムは複雑なため専門的なトレーニングが必要であり、これが導入の障壁となることもあります。さらに、汚染リスクと精密な環境制御の必要性は依然として根強く、検査の信頼性と全体的な業務効率に影響を及ぼす可能性があります。

米国の微生物学と細菌培養培地市場レポート・ハイライト

• 保存期間が長く保管が容易なことから、脱水培地が2024年に最大の売上シェアを占めました。さらに、費用対効果と調製の簡便性から、多くの研究室で好まれています。すぐに使える培地セグメントは、予測期間中に最も速いCAGRで成長すると予想されています。
• 医薬品・バイオ医薬品製造セグメントは、2024年に38.13％の最大の収益シェアでアプリケーションセグメントを支配し、予測期間中に最も速いCAGRで成長すると予測されています。この背景には、ワクチンや生物製剤の需要増加があります。品質と安全性試験に対する厳しい規制要件がさらに成長を後押ししています。しかし、診断薬は予測期間中に大きく成長する見込みです。
• 2024年10月、米国薬局方（USP）は、ミネソタ州セントポールに本社を置く微生物学テクノロジー企業Stratix Labsの買収を発表しました。この戦略的な動きはUSPのポートフォリオにとって重要な前進であり、生物製剤や配合剤を含む様々な医薬品アプリケーションにおける微生物汚染制御をサポートする微生物学的ソリューションを強化するものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国の微生物学と細菌培養培地市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 米国の微生物学と細菌培養培地市場：製品推定・動向分析

• セグメントダッシュボード
• 米国の微生物学と細菌培養培地市場の製品変動分析
• 米国の微生物学と細菌培養培地市場規模と動向分析（製品別、2018～2030年）
• 乾燥培養培地
• すぐに使えるメディア

第5章 米国の微生物学および細菌培養メディア市場：用途の推定・動向分析

• セグメントダッシュボード
• 米国の微生物学と細菌培養培地市場の用途変動分析
• 米国の微生物学と細菌培養培地市場規模と動向分析（用途別、2018～2030年）
• 食品と水の検査
  • 食品
  • 動物飼料
  • 水質検査
• 診断
• 医薬品およびバイオ医薬品製造
• バイオエネルギーと農業調査
• 化粧品およびパーソナルケア用途
• その他

第6章 競合情勢

• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • bioMerieux SA
  • HiMedia Laboratories
  • BD
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • SHIMADZU
  • Hardy Diagnostics
  • Alpha Teknova, Inc.
  • MP Biomedicals

List of Tables

• Table 1 U.S. microbiology & bacterial culture media market estimates & forecasts
• Table 2 U.S. microbiology & bacterial culture media market estimates & forecasts, by product, 2018 - 2030 (USD Million)
• Table 3 U.S. microbiology & bacterial culture media market estimates & forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market snapshot
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market trends & outlook
• Fig. 7 Market segmentation & scope
• Fig. 8 Market driver relevance analysis (Current & future impact)
• Fig. 9 Market restraint relevance analysis (Current & future impact)
• Fig. 10 PESTLE Analysis
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Strategy framework
• Fig. 13 Participant categorization
• Fig. 14 U.S. microbiology & bacterial culture media market: Product outlook key takeaways
• Fig. 15 U.S. microbiology & bacterial culture media market: Product movement analysis
• Fig. 16 Dehydrated culture media market, 2018 - 2030 (USD Million)
• Fig. 17 Ready-to-use media market, 2018 - 2030 (USD Million)
• Fig. 18 U.S. microbiology & bacterial culture media market: Application outlook key takeaways
• Fig. 19 U.S. microbiology & bacterial culture media market: Application movement analysis
• Fig. 20 Food & water testing market, 2018 - 2030 (USD Million)
• Fig. 21 Food market, 2018 - 2030 (USD Million)
• Fig. 22 Animal feed market, 2018 - 2030 (USD Million)
• Fig. 23 Water testing market, 2018 - 2030 (USD Million)
• Fig. 24 Diagnostics market, 2018 - 2030 (USD Million)
• Fig. 25 Pharmaceutical & biopharmaceutical production market, 2018 - 2030 (USD Million)
• Fig. 26 Bioenergy & agricultural research market, 2018 - 2030 (USD Million)
• Fig. 27 Cosmetics and Personal Care Applications market, 2018 - 2030 (USD Million)
• Fig. 28 Others market, 2018 - 2030 (USD Million)
• Fig. 29 U.S. microbiology & bacterial culture media market, 2018 - 2030 (USD Million)
• Fig. 30 Key companies profiled

U.S. Microbiology And Bacterial Culture Media Market Growth and Trends:

The U.S. microbiology and bacterial culture media market size is anticipated to reach USD 2.95 billion by 2030 and is anticipated to grow at a CAGR of 7.47% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to increasing demand for rapid diagnostics, rising prevalence of infectious diseases, expanding pharmaceutical and food testing applications, and continuous advancements in microbial culture technologies across clinical and industrial sectors.

The rising threat of antimicrobial resistance (AMR) has significantly increased the reliance on microbiology culture media for accurate identification of drug-resistant pathogens. As pathogens evolve resistance to conventional antibiotics, precise microbial detection becomes critical to guide effective treatment strategies. This growing awareness has spurred intensified research and development efforts aimed at combating AMR, fueling demand for advanced bacterial culture media. Consequently, microbiology culture remains a vital tool in pharmaceutical development, infection control, and clinical diagnostics, thus propelling the market growth across the region.

In addition, Continuous technological advancements in culture techniques, including automated systems and sophisticated identification methods, have revolutionized microbiology laboratories. These innovations streamline workflows, reduce manual errors, and significantly improve the accuracy and speed of microbial detection. Enhanced efficiency in sample processing and data analysis enables laboratories to meet growing demands for rapid and reliable results. Furthermore, these improvements support regulatory compliance and quality assurance in pharmaceutical, clinical, and research settings. Collectively, such advancements drive increased adoption of culture media, thereby stimulating sustained growth and competitiveness in the microbiology market.

However, the high costs associated with advanced equipment and culture media limit adoption, especially among smaller laboratories and in emerging markets. Additionally, the complexity of some automated systems requires specialized training, which can be a barrier to implementation. Furthermore, contamination risks and the need for precise environmental controls remain persistent, potentially impacting test reliability and overall operational efficiency.

U.S. Microbiology And Bacterial Culture Media Market Report Highlights:

• The dehydrated culture media held the largest revenue share in 2024, owing to its long shelf life and ease of storage. Additionally, its cost-effectiveness and convenience in preparation make it the preferred choice for many laboratories. The ready-to-use media segment is expected to grow at the fastest CAGR over the forecast period.
• The pharmaceutical & biopharmaceutical production segment dominated the application segment with the largest revenue share of 38.13% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by increased demand for vaccines and biologics. Stringent regulatory requirements for quality and safety testing further propel its growth. However,diagnostics are expected to grow significantly over the forecast period.
• In October 2024, the U.S. Pharmacopeia (USP) announced its acquisition of Stratix Labs, a microbiology technology company headquartered in Saint Paul, MN. This strategic move represents a significant advancement for USP's portfolio, enhancing its microbiological solutions to support microbial contamination control across various pharmaceutical applications, including biologics and compounded medications.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Application Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growth in global food microbiology testing
    • 3.2.1.2. Rising need for high-quality culture media for diagnostic applications
    • 3.2.1.3. Continuous advancements in biopharmaceutical manufacturing
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced or specialty media
    • 3.2.2.2. Growing preference for alternative methods like molecular diagnostics
• 3.3. U.S. Microbiology & Bacterial Culture Media Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Microbiology & Bacterial Culture Media Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. U.S. Microbiology & Bacterial Culture Media Market Product Movement Analysis
• 4.3. U.S. Microbiology & Bacterial Culture Media Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Dehydrated Culture Media
  • 4.4.1. Dehydrated Culture Media Market, 2018 - 2030 (USD Million)
• 4.5. Ready-to-use Media
  • 4.5.1. Ready-to-use Media Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Microbiology & Bacterial Culture Meida Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. U.S. Microbiology & Bacterial Culture Media Market Application Movement Analysis
• 5.3. U.S. Microbiology & Bacterial Culture Media Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Food & Water Testing
  • 5.4.1. Food & Water Testing Market, 2018 - 2030 (USD Million)
  • 5.4.2. Food
    • 5.4.2.1. Food Market, 2018 - 2030 (USD Million)
  • 5.4.3. Animal Feed
    • 5.4.3.1. Animal Feed Market, 2018 - 2030 (USD Million)
  • 5.4.4. Water Testing
    • 5.4.4.1. Water Testing Market, 2018 - 2030 (USD Million)
• 5.5. Diagnostics
  • 5.5.1. Diagnostics Market, 2018 - 2030 (USD Million)
• 5.6. Pharmaceutical & Biopharmaceutical Production
  • 5.6.1. Pharmaceutical & Biopharmaceutical Production Market, 2018 - 2030 (USD Million)
• 5.7. Bioenergy & Agricultural Research
  • 5.7.1. Bioenergy & Agricultural Research Market, 2018 - 2030 (USD Million)
• 5.8. Cosmetics and Personal Care Applications
  • 5.8.1. Cosmetics and Personal Care Applications Market, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Strategy Mapping
• 6.3. Company Profiles/Listing
  • 6.3.1. Thermo Fisher Scientific, Inc.
    • 6.3.1.1. Overview
    • 6.3.1.2. Financial Performance
    • 6.3.1.3. Product Benchmarking
    • 6.3.1.4. Strategic Initiatives
  • 6.3.2. Merck KGaA
    • 6.3.2.1. Overview
    • 6.3.2.2. Financial Performance
    • 6.3.2.3. Product Benchmarking
    • 6.3.2.4. Strategic Initiatives
  • 6.3.3. bioMerieux SA
    • 6.3.3.1. Overview
    • 6.3.3.2. Financial Performance
    • 6.3.3.3. Product Benchmarking
    • 6.3.3.4. Strategic Initiatives
  • 6.3.4. HiMedia Laboratories
    • 6.3.4.1. Overview
    • 6.3.4.2. Financial Performance
    • 6.3.4.3. Product Benchmarking
    • 6.3.4.4. Strategic Initiatives
  • 6.3.5. BD
    • 6.3.5.1. Overview
    • 6.3.5.2. Financial Performance
    • 6.3.5.3. Product Benchmarking
    • 6.3.5.4. Strategic Initiatives
  • 6.3.6. Neogen Corporation
    • 6.3.6.1. Overview
    • 6.3.6.2. Financial Performance
    • 6.3.6.3. Product Benchmarking
    • 6.3.6.4. Strategic Initiatives
  • 6.3.7. Bio-Rad Laboratories, Inc.
    • 6.3.7.1. Overview
    • 6.3.7.2. Financial Performance
    • 6.3.7.3. Product Benchmarking
    • 6.3.7.4. Strategic Initiatives
  • 6.3.8. SHIMADZU
    • 6.3.8.1. Overview
    • 6.3.8.2. Financial Performance
    • 6.3.8.3. Product Benchmarking
    • 6.3.8.4. Strategic Initiatives
  • 6.3.9. Hardy Diagnostics
    • 6.3.9.1. Overview
    • 6.3.9.2. Financial Performance
    • 6.3.9.3. Product Benchmarking
    • 6.3.9.4. Strategic Initiatives
  • 6.3.10. Alpha Teknova, Inc.
    • 6.3.10.1. Overview
    • 6.3.10.2. Financial Performance
    • 6.3.10.3. Product Benchmarking
    • 6.3.10.4. Strategic Initiatives
  • 6.3.11. MP Biomedicals
    • 6.3.11.1. Overview
    • 6.3.11.2. Financial Performance
    • 6.3.11.3. Product Benchmarking
    • 6.3.11.4. Strategic Initiatives